Kerala Medical Services Corporation not procured rabies vaccine without CDL certificate: Health Minister

Published On 2025-08-04 10:53 GMT | Update On 2025-08-04 10:53 GMT

JP Nadda

New Delhi: The Kerala Medical Services Corporation (KMSCL) has not procured or distributed any batch of rabies vaccine or equine anti-rabies immunoglobulin without a batch release certificate from the Central Drugs Laboratory (CDL), Union Health Minister J P Nadda informed Parliament.

Nadda said this in a reply to a question raised in Lok Sabha, whether the manufacturers supplying anti-rabies vaccine to KMSCL had done the mandatory tests from the CDL during the last five years and the current year.

"As informed by Kerala Medical Services Corporation (KMSCL), all Rabies Vaccines and Equine Anti-Rabies Immunoglobulins procured and distributed by them from the tender year 2016-17 onwards have obtained Batch Release Certificates from Central Drugs Laboratory (CDL), Kasauli, as mandated in the tender terms and conditions," Nadda said.

"KMSCL has not procured or distributed any batch of Rabies vaccine or Equine Anti-rabies Immunoglobulin without a batch release certificate from CDL," Nadda said.

For the manufacturing or import of new drugs, including vaccines, the manufacturers and importers are required to comply with the standards of quality, safety and efficacy as prescribed in the Drugs and Cosmetics Act, 1940 and Rules.

The mandatory quality requirements prescribed to ensure the quality of anti-rabies vaccines being manufactured in the country include a manufacturing licence and import licence issued under the Drugs and Cosmetics Act and Rules and that the anti-rabies vaccine must comply with the standards specified in the current edition of the Indian Pharmacopoeia.

Each batch must undergo complete in-house quality control testing at the manufacturer's facility according to validated procedures and IP standards.

Each batch or lot of vaccines manufactured or imported in the country is required to be released by the CDL at Kasauli in Himachal Pradesh before the release of vaccines for sale and distribution, Nadda explained.

According to PTI, he said that proper cold chain logistics, two degrees Celsius to eight degrees Celsius must be maintained throughout storage and transportation to preserve vaccine potency and vaccines must have a valid remaining shelf life at the time of supply and should be packaged to ensure protection during transit and storage.

According to Rule 2(w) of New Drugs and Clinical Trial Rules, 2019, vaccines are always deemed to be new drugs.

All manufacturers of vaccines have to comply with the conditions of mandatory quality tests apart from other conditions of licence as prescribed under Rules 78 and 78A of Drug Rules, 1945 and both the Central License Approving Authority (CLAA) and state licensing authorities are empowered to take stringent action against violation of provisions of the Act and Rules.

Article Source : with inputs

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Kerala Medical Services Corporation not procured rabies vaccine without CDL certificate: Health Minister

Similar News

Health Ministry Amends Drugs Rules, Mandates Endotoxin Testing and Updates Licensing Conditions

Zydus Lifesciences Secures USFDA Final Approvals for Ivermectin and Dapsone Tablets

Kerala Extends Free Risdiplam Supply to SMA Patients Up to 25 Years

NPPA Fixes Retail Prices of 20 New Drug Formulations Under DPCO 2013

Five Pharmacists Booked for Allegedly Selling Counterfeit Life-Saving Medicines

Mankind Pharma Gets Relief as CGST Appellate Authority Drops Rs 1.02 Cr Penalty

Delhi Court Clears Aurobindo Promoter in High-Profile Excise Policy Probe

Meropenem, Ritonavir Back in Focus as DoP Reopens PLI Application Window Till March 12